WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

FDA To Review Safety Of Abortion Pill After Junk Science Report Paved The Way

Republicans have been laying the groundwork to undermine the safety of mifepristone for months, despite the drug's proven safety record.

Raccontata dahuffpost.comupi.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
huffpost.comStai leggendo1 anni fa

FDA To Review Safety Of Abortion Pill After Junk Science Report Paved The Way

Republicans have been laying the groundwork to undermine the safety of mifepristone for months, despite the drug's proven safety record.

originale
upi.com1 anni fa

FDA commissioner Marty Makary to review safety of abortion drug mifepristone - UPI.com

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 3 giugno 2025·huffpost.com

    FDA To Review Safety Of Abortion Pill After Junk Science Report Paved The Way

    Republicans have been laying the groundwork to undermine the safety of mifepristone for months, despite the drug's proven safety record.

  2. mercoledì 4 giugno 2025·upi.com

    FDA commissioner Marty Makary to review safety of abortion drug mifepristone - UPI.com

    Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side…